Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equipment, Net

Equipment, Net

3 Months Ended

Mar. 31, 2012

6.	Equipment, Net

	March 31,			December 31,
	2012			2011

Furniture and fixtures	$	34,200		$	34,200
Office equipment		81,074			81,074
Lab and computer equipment		430,261			430,261
Leasehold improvements		119,841			119,841

Total fixed assets		665,376			665,376
Less: Accumulated depreciation		(581,555	)		(570,834	)

Net carrying amount	$	83,821		$	94,542

Depreciation expense was $10,721 and $14,127 for the three months ended March 31, 2012 and 2011, respectively.

- Definition

The entire disclosure for long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details